Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and Staphylococcus aureus

Study limitation reported by the research below: “No sample size (N) is applicable in the traditional sense — this is a laboratory strain study using bacterial reference strains, not human subjects.”